Sociodemographic profile of medicines users in brazil: results from the 2014 pnaum survey

dc.contributor.authorBertoldi, Andrea Damaso
dc.contributor.authorDal Pizzol, Tatiane da Silva
dc.contributor.authorRamos, Luiz Roberto [UNIFESP]
dc.contributor.authorMengue, Sotero Serrate
dc.contributor.authorLuiza, Vera Lucia
dc.contributor.authorLeao Tavares, Noemia Urruth
dc.contributor.authorFarias, Mareni Rocha
dc.contributor.authorOliveira, Maria Auxiliadora
dc.contributor.authorDourado Arrais, Paulo Sergio
dc.date.accessioned2019-01-21T10:29:34Z
dc.date.available2019-01-21T10:29:34Z
dc.date.issued2016
dc.description.abstractOBJECTIVE: To analyze the prevalence of medicine use by the Brazilian population and its distribution according to sociodemographic factors. METHODS: Study using data from the Pesquisa Nacional de Acesso, Utilizacao e Promocao do Uso Racional de Medicamentos (PNAUM - National Survey on Access, Use and Promotion of Rational Use of Medicines), a nationwide household survey of a representative sample of the Brazilian urban population. The data were collected between September 2013 and February 2014. The overall use of medicines, defined as the use of any medicine, use of medicines for treating chronic medical conditions and for acute health conditions, was evaluated. The independent variables included gender, age group, socioeconomic position, and region of Brazil. Analyzes included prevalence calculations, 95% confidence intervals (95% CI) and Pearson Chi-square tests to evaluate the differences between groups, considering a 5% level of significance. RESULTS: The prevalence of medicines use was 50.7% (95% CI 49.3-52.2), with 39.3% (95% CI 37.5-41.1) accounting for men and 61.0% (95% CI 59.3-62.6) for women. Medicines use was observed to increase with increasing age, except among children within the zero to four years age group. The lowest prevalence for medicines use was found among those with a low socioeconomic position and those who reside in the North region of Brazil. The prevalence of medicine use to treat chronic diseases was 24.3% (95% CI 23.3-25.4), whereas it was 33.7% (95% CI 32.1-35.4) for treating acute diseases. CONCLUSIONS: We found extensive variability in the prevalence of medicines use across regions of Brazil. The poorest regions (North, Northeast, and Midwest) have a lower prevalence of medicines use to treat chronic diseases, indicating the need to minimize inequalities in access to medicines within the country.en
dc.description.affiliationDepartamento de Medicina Social. Faculdade de Medicina. Universidade Federal de Pelotas. Pelotas, RS, Brasil
dc.description.affiliationDepartamento de Produção e Controle de Medicamentos. Faculdade de Farmácia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliationDepartamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.affiliationPrograma de Pós-Graduação em Epidemiologia. Faculdade de Medicina. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliationDepartamento de Política de Medicamentos e Assistência Farmacêutica. Escola Nacional de Saúde Pública Sérgio Arouca. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil
dc.description.affiliationDepartamento de Farmácia. Faculdade de Ciências da Saúde. Universidade de Brasília. Brasília, DF, Brasil
dc.description.affiliationDepartamento de Ciências Farmacêuticas. Centro de Ciências da Saúde. Universidade Federal de Santa Catarina. Florianópolis, SC, Brasil
dc.description.affiliationDepartamento de Farmácia. Faculdade de Farmácia, Odontologia e Enfermagem. Universidade Federal do Ceará. Fortaleza, CE, Brasil
dc.description.affiliationUnifespDepartamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.sourceWeb of Science
dc.description.sponsorshipDepartment of Pharmaceutical Services and Strategic Health Supplies (DAF) of the Secretariat of Science, Technology and Strategic Inputs from the Ministry of Health (SCTIE/MS) [25000,111834/2]
dc.description.sponsorshipDepartment of Science and Technology (DECIT) of the Secretariat of Science, Technology and Strategic Inputs from the Ministry of Health (SCTIE/MS) [25000,111834/2]
dc.description.sponsorshipIDSCTIE/MS: 25000,111834/2
dc.format.extent5s
dc.identifierhttp://dx.doi.org/10.1590/s1518-8787.2016050006119
dc.identifier.citationRevista De Saude Publica. Sao paulo, v. 50, n. 2, p. 5s, 2016.
dc.identifier.doi10.1590/S1518-8787.2016050006119
dc.identifier.fileS0034-89102016000300310.pdf
dc.identifier.issn0034-8910
dc.identifier.scieloS0034-89102016000300310
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/49277
dc.identifier.wosWOS:000391447400004
dc.language.isoeng
dc.publisherHindawi Publishing Corp
dc.relation.ispartofRevista De Saude Publica
dc.rightsAcesso aberto
dc.subjectDrug Utilizationen
dc.subjectSelf-Medicationen
dc.subjectSao-Pauloen
dc.subjectAdultsen
dc.subjectCampinasen
dc.titleSociodemographic profile of medicines users in brazil: results from the 2014 pnaum surveyen
dc.titlePerfil sociodemográfico dos usuários de medicamentos no Brasil: resultados da PNAUM 2014pt
dc.typeArtigo
Arquivos
Coleções